These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22999555)

  • 41. Human growth hormone for poor responders: a randomized placebo-controlled trial provides no evidence for improved live birth rate.
    Norman RJ; Alvino H; Hull LM; Mol BW; Hart RJ; Kelly TL; Rombauts L;
    Reprod Biomed Online; 2019 Jun; 38(6):908-915. PubMed ID: 30954433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).
    Kwan I; Bhattacharya S; McNeil A; van Rumste MM
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005289. PubMed ID: 18425917
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The probability of successful IVF outcome after poor ovarian response.
    Saldeen P; Källen K; Sundström P
    Acta Obstet Gynecol Scand; 2007; 86(4):457-61. PubMed ID: 17486468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Individualized follicle-stimulating hormone dosing and in vitro fertilization outcome in agonist downregulated cycles: a systematic review.
    van Tilborg TC; Broekmans FJ; Dólleman M; Eijkemans MJ; Mol BW; Laven JS; Torrance HL
    Acta Obstet Gynecol Scand; 2016 Dec; 95(12):1333-1344. PubMed ID: 27687487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
    Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
    Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modified super-long down-regulation protocol improves fertilization and pregnancy in patients with poor ovarian responses.
    Zhang HJ; Song XR; Lü R; Xue FX
    Chin Med J (Engl); 2012 Aug; 125(16):2837-40. PubMed ID: 22932076
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF.
    Pu D; Wu J; Liu J
    Hum Reprod; 2011 Oct; 26(10):2742-9. PubMed ID: 21778283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Do poor-responder patients benefit from increasing the daily gonadotropin dose from 300 to 450 IU during controlled ovarian hyperstimulation for IVF?].
    Haas J; Zilberberg E; Kedem A; Dar S; Orvieto R
    Harefuah; 2015 Feb; 154(2):114-7, 135. PubMed ID: 25856865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A prospective comparative study on IVF outcomes with either purified FSH or human menopausal gonadotrophin in downregulated normogonadotrophic women.
    Ismail AF; Hesham AI; Salah Z; Khaled M; Fouad N; Ashraf N; Hatem S; Hamdi B
    Gynecol Obstet Invest; 2002; 53(4):220-3. PubMed ID: 12186987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count.
    Jayaprakasan K; Hopkisson J; Campbell B; Johnson I; Thornton J; Raine-Fenning N
    BJOG; 2010 Jun; 117(7):853-62. PubMed ID: 20353458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization.
    Berin I; Stein DE; Keltz MD
    Fertil Steril; 2010 Feb; 93(2):360-3. PubMed ID: 19131055
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of prolonging administration gonadotropin on unexpectedly poor ovarian responders undergoing in vitro fertilization.
    Wei Z; Cheng X; Li H; Cao Y; Cong L; Zhou P; Li J
    Reprod Biol Endocrinol; 2010 Mar; 8():26. PubMed ID: 20236519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased risk of preterm birth and low birthweight with very high number of oocytes following IVF: an analysis of 65 868 singleton live birth outcomes.
    Sunkara SK; La Marca A; Seed PT; Khalaf Y
    Hum Reprod; 2015 Jun; 30(6):1473-80. PubMed ID: 25883033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study.
    König TE; van der Houwen LE; Overbeek A; Hendriks ML; Beutler-Beemsterboer SN; Kuchenbecker WK; Renckens CN; Bernardus RE; Schats R; Homburg R; Hompes PG; Lambalk CB
    Hum Reprod; 2013 Oct; 28(10):2804-12. PubMed ID: 23838159
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis.
    Kolibianakis EM; Venetis CA; Diedrich K; Tarlatzis BC; Griesinger G
    Hum Reprod Update; 2009; 15(6):613-22. PubMed ID: 19561136
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial.
    Xu Y; Nisenblat V; Lu C; Li R; Qiao J; Zhen X; Wang S
    Reprod Biol Endocrinol; 2018 Mar; 16(1):29. PubMed ID: 29587861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
    Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of GnRH agonist versus luteal estradiol GnRH antagonist protocol using transdermal testosterone in poor responders.
    Fàbregues F; Solernou R; Ferreri J; Guimerá M; Peralta S; Casals G; Peñarrubia J; Creus M; Manau D
    JBRA Assist Reprod; 2019 Apr; 23(2):130-136. PubMed ID: 30614665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.